GSK Investigational Site

Klaipėda LT-92288

0 studies enrolling now · 8 studies all time

What they study most

Arthritis, Rheumatoid, Asthma, Deep Vein Thrombosis, Fibrillation, Atrial, Nausea, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast, Prostatic Hyperplasia, Pulmonary Embolism, Systemic Lupus Erythematosus, Venous Thromboembolism, Vomiting

Studies at this site

• Belimumab Assessment of Safety in SLE — Completed
• Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
• Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors — Completed
• SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. — Completed
• Odiparcil For The Prevention Of Venous Thromboembolism — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed
• Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting — Completed